HRTX
Heron Therapeutics Inc
Price:  
2.75 
USD
Volume:  
1,577,605.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRTX Relative Valuation

-699.0%
Upside

As of 2024-02-22, the Relative Valuation of Heron Therapeutics Inc (HRTX) is (16.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.75 USD, the upside of Heron Therapeutics Inc based on Relative Valuation is -699.0%.

The range of the Relative Valuation is (16.08) - (16.74) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 16.4x - 21.0x 20.1x
Forward P/E multiples 20.2x - 21.3x 21.2x
Fair Price (16.08) - (16.74) (16.47)
Upside -684.8% - -708.6% -699.0%
2.75 USD
Stock Price
(16.47) USD
Fair Price

HRTX Relative Valuation - Historical P/E Data

Date P/E
2024-02-21 -3.45
2024-02-20 -3.60
2024-02-16 -3.60
2024-02-15 -3.61
2024-02-14 -3.41
2024-02-13 -3.15
2024-02-12 -3.30
2024-02-09 -3.05
2024-02-08 -2.95
2024-02-07 -2.83
2024-02-06 -2.91
2024-02-05 -2.80
2024-02-02 -3.00
2024-02-01 -3.01
2024-01-31 -3.02
2024-01-30 -3.12
2024-01-29 -3.17
2024-01-26 -3.12
2024-01-25 -3.36
2024-01-24 -3.28
2024-01-23 -2.76
2024-01-22 -2.93
2024-01-19 -2.62
2024-01-18 -2.62
2024-01-17 -2.76
2024-01-16 -2.76
2024-01-12 -2.70
2024-01-11 -2.70
2024-01-10 -2.79
2024-01-09 -2.83
2024-01-08 -2.62
2024-01-05 -2.22
2024-01-04 -2.17
2024-01-03 -2.14
2024-01-02 -2.37
2023-12-29 -2.13
2023-12-28 -2.18
2023-12-27 -2.09
2023-12-26 -2.22
2023-12-22 -2.24
2023-12-21 -2.18
2023-12-20 -2.03
2023-12-19 -2.18
2023-12-18 -2.18
2023-12-15 -2.27
2023-12-14 -2.28
2023-12-13 -2.11
2023-12-12 -2.11
2023-12-11 -1.91
2023-12-08 -1.87